Efficacy and Safety of Bromfenac Ophthalmic Solution

Completed · Phase 2

Conditions studied: Cataract Surgery

In brief

This is a safety and efficacy study of bromfenac ophthalmic solution

Key facts

Study ID

NCT00585975

Run by

Bausch & Lomb Incorporated

People needed

568

Starts

2007-10-01

Last updated by the study team

2013-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female greater than or equal to 18 years of age, and scheduled for cataract surgery

You may not qualify if…

• Active corneal pathology in either eye

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.